Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Overall, there was a significant association between low 25OHD levels and elevated depressive symptoms (odds ratio [OR] = 1.58, 95% confidence interval [CI] = 1.20 to 2.07 for the lowest quartile; OR = 1.45, 95% CI = 1.15 to 1.83 for <30 nmol/L cut-off and OR = 1.34, 95% CI = 1.10 to 1.62 for the ≤50 nmol/L cut-off) after adjustment for a wide range of covariates of clinical significance.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

A complete case analysis with a final analytical sample of 5,607 participants was performed.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Associations Between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence From the English Longitudinal Study of Ageing (ELSA)

Study design awaiting verification · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · 2018

Original publication title

Associations Between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence From the English Longitudinal Study of Ageing (ELSA)

Cesar de Oliveira; Vasant Hirani; Jane P Biddulph

© The Author(s) 2017. Published by Oxford University Press on behalf of The Gerontological Society of America.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

The independent and inverse association found between low 25OHD levels and elevated depressive symptoms suggests that vitamin D deficiency may be a risk factor for late-life depression, particularly among women. Whether our findings have any clinical meaning or not, additional data are needed from well-designed randomized controlled trials of vitamin D for the prevention and treatment of late-life depression.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

A possible role of vitamin D in depression has received considerable attention, especially given the significant disability, mortality, and healthcare costs associated to depression and the high prevalence of vitamin D deficiency.

Source: Background

Abstract: What methods does the paper describe?

We investigated the cross-sectional associations between serum 25-hydroxyvitamin D (25OHD) levels and depressive symptoms (CES-D) in 5,607 older adults from the English Longitudinal Study of Ageing (ELSA).

Source: Methods

Abstract: Results

Overall, there was a significant association between low 25OHD levels and elevated depressive symptoms (odds ratio [OR] = 1.58, 95% confidence interval [CI] = 1.20 to 2.07 for the lowest quartile; OR = 1.45, 95% CI = 1.15 to 1.83 for <30 nmol/L cut-off and OR = 1.34, 95% CI = 1.10 to 1.62 for the ≤50 nmol/L cut-off) after adjustment for a wide range of covariates of clinical significance. Fully adjusted models showed that women in the lowest (OR = 1.67, 95% CI = 1.20 to 2.34) and second lowest (OR = 1.68, 95% CI = 1.20 to 2.35) quartiles of 25OHD as well as those with 25OHD levels <30 nmol/L (OR = 1.40, 95% CI = 1.06 to 1.86) and ≤50 nmol/L (OR = 1.35, 95% CI = 1.07 to 1.72) were more likely to report elevated depressive symptoms.

For men, however, this association only remained significant for those with 25OHD levels of <30 nmol/L (OR = 1.60, 95% CI = 1.06 to 2.42) in the fully adjusted models.

Source: Results

Abstract: Conclusions

The independent and inverse association found between low 25OHD levels and elevated depressive symptoms suggests that vitamin D deficiency may be a risk factor for late-life depression, particularly among women. Whether our findings have any clinical meaning or not, additional data are needed from well-designed randomized controlled trials of vitamin D for the prevention and treatment of late-life depression.

Source: Conclusions
Authors’ abstract

Abstract

Background

A possible role of vitamin D in depression has received considerable attention, especially given the significant disability, mortality, and healthcare costs associated to depression and the high prevalence of vitamin D deficiency.

Methods

We investigated the cross-sectional associations between serum 25-hydroxyvitamin D (25OHD) levels and depressive symptoms (CES-D) in 5,607 older adults from the English Longitudinal Study of Ageing (ELSA).

Results

Overall, there was a significant association between low 25OHD levels and elevated depressive symptoms (odds ratio [OR] = 1.58, 95% confidence interval [CI] = 1.20 to 2.07 for the lowest quartile; OR = 1.45, 95% CI = 1.15 to 1.83 for <30 nmol/L cut-off and OR = 1.34, 95% CI = 1.10 to 1.62 for the ≤50 nmol/L cut-off) after adjustment for a wide range of covariates of clinical significance. Fully adjusted models showed that women in the lowest (OR = 1.67, 95% CI = 1.20 to 2.34) and second lowest (OR = 1.68, 95% CI = 1.20 to 2.35) quartiles of 25OHD as well as those with 25OHD levels <30 nmol/L (OR = 1.40, 95% CI = 1.06 to 1.86) and ≤50 nmol/L (OR = 1.35, 95% CI = 1.07 to 1.72) were more likely to report elevated depressive symptoms.

For men, however, this association only remained significant for those with 25OHD levels of <30 nmol/L (OR = 1.60, 95% CI = 1.06 to 2.42) in the fully adjusted models.

Conclusions

The independent and inverse association found between low 25OHD levels and elevated depressive symptoms suggests that vitamin D deficiency may be a risk factor for late-life depression, particularly among women. Whether our findings have any clinical meaning or not, additional data are needed from well-designed randomized controlled trials of vitamin D for the prevention and treatment of late-life depression.

Publication and source details

Original title: Associations Between Vitamin D Levels and Depressive Symptoms in Later Life: Evidence From the English Longitudinal Study of Ageing (ELSA)

Cesar de Oliveira; Vasant Hirani; Jane P Biddulph

The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · 2018

Address correspondence to: Cesar de Oliveira, PhD, Senior Research Fellow, Department of Epidemiology & Public Health, English Longitudinal Study of Ageing (ELSA), University College London, 1 to 19 Torrington Place, WC1E 6BT, London, UK. E-mail: c.oliveira@ucl.ac.uk© The Author(s) 2017. Published by Oxford University Press on behalf of The Gerontological Society of America.2017https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.National Institute on Aging10.13039/1000000495 R01 AG017644-16Economic and Social Research Council10.13039/501100000269

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:46:50.392837+00:00

DOI: 10.1093/gerona/glx130 · PMC6132123